Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.
暂无分享,去创建一个
Nathaniel Rothman | Montserrat Garcia-Closas | Stephen Chanock | Sholom Wacholder | N. Rothman | S. Chanock | M. García-Closas | S. Wacholder | L. El ghormli | Laure El Ghormli | Laure El ghormli
[1] G. Fraser. Human Genome Epidemiology: A scientific foundation for using genetic information to improve health and prevent disease , 2005 .
[2] W. Browner,et al. Are all significant P values created equal? The analogy between diagnostic tests and clinical research. , 1987, JAMA.
[3] John S Witte,et al. Point: population stratification: a problem for case-control studies of candidate-gene associations? , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] N. Saitou,et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.
[5] R. Tibshirani,et al. Empirical bayes methods and false discovery rates for microarrays , 2002, Genetic epidemiology.
[6] P. McKeigue,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Problems of Reporting Genetic Associations with Complex Outcomes , 2022 .
[7] Henry J. Lin,et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. , 2002, American journal of epidemiology.
[8] Jonathan A C Sterne,et al. Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.
[9] E. Lander,et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.
[10] Christine B Ambrosone,et al. SNPs, haplotypes, and cancer: applications in molecular epidemiology. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[12] N. Risch. Searching for genetic determinants in the new millennium , 2000, Nature.
[13] N E Morton,et al. Tests and estimates of allelic association in complex inheritance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] N Risch,et al. The Future of Genetic Studies of Complex Human Diseases , 1996, Science.
[15] T. Sellers. Genetic ancestry and molecular epidemiology. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[16] C. Ulrich,et al. Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[17] Chiara Sabatti,et al. False discovery rate in linkage and association genome screens for complex disorders. , 2003, Genetics.
[18] N. Rothman,et al. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. , 2000, Pharmacogenetics.
[19] J. Ioannidis,et al. Replication validity of genetic association studies , 2001, Nature Genetics.
[20] C. Weinberg,et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. , 2002, American journal of epidemiology.
[21] Paul D P Pharoah,et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. , 2002, Human molecular genetics.
[22] N. Schork,et al. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. , 2001, Genome research.
[23] D. Clayton,et al. Betting odds and genetic associations. , 2004, Journal of the National Cancer Institute.
[24] D. Botstein,et al. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.
[25] Nathaniel Rothman,et al. Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .
[26] J. Hirschhorn,et al. A comprehensive review of genetic association studies , 2002, Genetics in Medicine.
[27] D. Cox. Another comment on the role of statistical methods. , 2001, Physical therapy.
[28] A. Tversky,et al. BELIEF IN THE LAW OF SMALL NUMBERS , 1971, Pediatrics.
[29] N. Rothman,et al. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. , 2000, Journal of the National Cancer Institute.
[30] Stephen Chanock,et al. Candidate Genes and Single Nucleotide Polymorphisms (SNPs) in the Study of Human Disease , 2002, Disease markers.
[31] Steven Goodman. Toward Evidence-Based Medical Statistics. 2: The Bayes Factor , 1999, Annals of Internal Medicine.
[32] C R Weinberg. It's time to rehabilitate the P-value. , 2001, Epidemiology.
[33] Nathaniel Rothman,et al. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[34] K J Rothman,et al. No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.
[35] J. Chang-Claude,et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability , 2000, Nature Genetics.
[36] S. Henikoff,et al. Accounting for human polymorphisms predicted to affect protein function. , 2002, Genome research.